Biogen Alzheimer’s Drug Slows Progression of Disease in Trial
Alert: HALISTER Source: BN (Bloomberg News)
Tickers BIIB US (Biogen Idec Inc) 3400398Z US (HHS Food & Drug Administration) PFE US (Pfizer Inc) ROG VX (Roche Holding AG)
People Alfred Sandrock (Biogen Idec Inc) George Scangos (Biogen Idec Inc)
Topics Alzheimers Disease Medical, Health Research Trends in Aging
To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.
UUID: 7947283